Carl Zeiss Meditec (ETR:AFX) received a €93.00 ($108.14) price objective from equities researchers at Berenberg Bank in a report released on Wednesday, Borsen Zeitung reports. The brokerage currently has a “neutral” rating on the stock. Berenberg Bank’s target price indicates a potential downside of 14.05% from the stock’s previous close.
Several other research analysts have also recently weighed in on AFX. Nord/LB set a €98.00 ($113.95) price objective on Carl Zeiss Meditec and gave the stock a “neutral” rating in a research report on Wednesday, August 21st. Deutsche Bank set a €89.00 ($103.49) price target on Carl Zeiss Meditec and gave the company a “neutral” rating in a research report on Monday, August 12th. DZ Bank reaffirmed a “neutral” rating on shares of Carl Zeiss Meditec in a research report on Monday, August 26th. Independent Research set a €90.00 ($104.65) price target on Carl Zeiss Meditec and gave the company a “sell” rating in a research report on Friday, August 23rd. Finally, HSBC set a €98.00 ($113.95) price target on Carl Zeiss Meditec and gave the company a “neutral” rating in a research report on Tuesday, September 17th. Two analysts have rated the stock with a sell rating and seven have assigned a hold rating to the company’s stock. Carl Zeiss Meditec presently has an average rating of “Hold” and a consensus price target of €86.00 ($100.00).
AFX stock traded up €2.60 ($3.02) during midday trading on Wednesday, hitting €108.20 ($125.81). The company’s stock had a trading volume of 198,283 shares, compared to its average volume of 94,405. The stock’s 50-day moving average price is €102.55 and its 200 day moving average price is €89.99. The company has a quick ratio of 3.09, a current ratio of 4.11 and a debt-to-equity ratio of 4.55. Carl Zeiss Meditec has a 1 year low of €60.25 ($70.06) and a 1 year high of €110.90 ($128.95). The stock has a market cap of $9.68 billion and a price-to-earnings ratio of 63.20.
Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.
Featured Article: Accumulation/Distribution
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.